ATE79549T1 - Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel. - Google Patents

Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.

Info

Publication number: ATE79549T1
Authority: AT; Austria
Prior art keywords: cough; antihistaminic; sedative; cold; cold remedies
Prior art date: 1987-06-08

Application number

AT88905521T

Other languages

English (en)

Inventor

Abraham Sunshine

Eugene M Laska

Carole E Siegel

Original Assignee

Analgesic Associates

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-08

Filing date

1988-06-06

Publication date

1992-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22024247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE79549(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-06-06 Application filed by Analgesic Associates filed Critical Analgesic Associates

1992-09-15 Application granted granted Critical

1992-09-15 Publication of ATE79549T1 publication Critical patent/ATE79549T1/de

Links

206010011224 Cough Diseases 0.000 title abstract 2
230000001387 anti-histamine Effects 0.000 title abstract 2
239000000739 antihistaminic agent Substances 0.000 title abstract 2
239000000932 sedative agent Substances 0.000 title 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 2
229940124584 antitussives Drugs 0.000 abstract 2
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
206010019233 Headaches Diseases 0.000 abstract 1
208000002193 Pain Diseases 0.000 abstract 1
206010037660 Pyrexia Diseases 0.000 abstract 1
SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 abstract 1
ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 abstract 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
239000003434 antitussive agent Substances 0.000 abstract 1
239000000850 decongestant Substances 0.000 abstract 1
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
239000003172 expectorant agent Substances 0.000 abstract 1
230000003419 expectorant effect Effects 0.000 abstract 1
231100000869 headache Toxicity 0.000 abstract 1
206010022000 influenza Diseases 0.000 abstract 1
206010025482 malaise Diseases 0.000 abstract 1
229960005489 paracetamol Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229960000581 salicylamide Drugs 0.000 abstract 1
230000001624 sedative effect Effects 0.000 abstract 1
229960004025 sodium salicylate Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Detergent Compositions (AREA)

AT88905521T 1987-06-08 1988-06-06 Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel. ATE79549T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US07/059,635 US4829064A (en)	1987-06-08	1987-06-08	Cough/cold mixtures comprising non-sedating antihistamine drugs
EP88905521A EP0316434B2 (de)	1987-06-08	1988-06-06	Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel
PCT/US1988/001835 WO1988009656A1 (en)	1987-06-08	1988-06-06	Cough/cold mixtures comprising non-sedating antihistamine drugs

Publications (1)

Publication Number	Publication Date
ATE79549T1 true ATE79549T1 (de)	1992-09-15

Family

ID=22024247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88905521T ATE79549T1 (de)	1987-06-08	1988-06-06	Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.

Country Status (7)

Country	Link
US (1)	US4829064A (de)
EP (1)	EP0316434B2 (de)
AT (1)	ATE79549T1 (de)
AU (1)	AU618010B2 (de)
CA (2)	CA1313136C (de)
DE (1)	DE3873879T2 (de)
WO (1)	WO1988009656A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5271946A (en) *	1988-04-20	1993-12-21	Asta Pharma Aktiengesellschaft	Controlled release azelastine-containing pharmaceutical compositions
US4990535A (en) *	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
EP0421825A1 (de) *	1989-08-11	1991-04-10	Kadem Farmaseutiese Produktie B.K.	Paracetamol enthaltende Lösungen
US5250529A (en) *	1990-02-08	1993-10-05	Kos Pharmaceuticals, Inc.	Method alleviating migraine headache with mast cell degranulation blocking agents
FR2673842B1 (fr) *	1991-03-13	1993-12-24	Rhone Poulenc Rorer Sa	Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
DE122004000032I2 (de)	1991-09-06	2006-02-09	Mcneilab Inc	Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
FR2684298B1 (fr) *	1991-12-03	1994-03-11	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
IT1255639B (it) *	1992-07-30	1995-11-09		Uso dell'oxatomide come agente antitosse
WO1994003170A1 (en) †	1992-08-03	1994-02-17	Sepracor Inc.	Terfenadine metabolites and their optically pure isomers for treating allergic disorders
AU5136193A (en) *	1992-09-24	1994-04-12	Sepracor, Inc.	Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
DK0707475T3 (da) *	1993-06-14	1997-12-29	Janssen Pharmaceutica Nv	Langsom frigørende, filmcoatet tablet af astemizol og pseudoephedrin
US5906747A (en) *	1995-11-13	1999-05-25	Biosepra Inc.	Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US6469009B1 (en)	1996-04-08	2002-10-22	Ucb, S.A.	Pharmaceutical compositions for the treatment of rhinitis
US6348216B1 (en) *	1996-06-10	2002-02-19	Knoll Pharmaceutical Company	Ibuprofen and narcotic analgesic compositions
US6361794B1 (en)	1996-06-12	2002-03-26	Basf Corporation	Method of making ibuprofen and narcotic analgesic composition
ZA984336B (en) *	1997-05-21	1998-11-30	Warner Lambert Co	Non-sedating acrivastine product
US6194431B1 (en)	1998-04-14	2001-02-27	Paul D. Rubin	Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6132758A (en) *	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup
PE20001070A1 (es) *	1998-09-10	2000-10-19	Schering Corp	Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
PA8500101A1 (es) *	2000-03-30	2002-09-17	Schering Corp	Composiciones y métodos para tratar condiciones alérgicas e inflamatorias con tos
ES2170008B1 (es) *	2000-08-25	2003-05-01	Soc Es Carburos Metalicos Sa	Procedimiento para la precipitacion de particulas solidas finamente divididas.
MXPA03011705A (es) *	2001-06-20	2004-03-19	Schering Corp	Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal.
US7189757B2 (en)	2001-10-16	2007-03-13	Hypnion, Inc.	Treatment of sleep disorders using CNS target modulators
AU2002347906A2 (en)	2001-10-16	2003-04-28	Hypnion, Inc.	Treatment of CNS disorders using CNS target modulators
CZ292874B6 (cs) *	2002-01-30	2003-12-17	Léčiva, A. S.	Farmaceutický prostředek k ošetření akutních bolestí
US20040253311A1 (en) *	2002-12-18	2004-12-16	Roger Berlin	Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
TWI313598B (en) *	2002-12-18	2009-08-21	Wyeth Corp	Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20050020608A1 (en) *	2003-03-25	2005-01-27	Dr. Reddy's Laboratories Limited	Crystalline cetirizine monohydrochloride
EP2522365B1 (de)	2004-11-24	2016-10-26	Meda Pharmaceuticals Inc.	Zusammensetzungen aus Azelastin und Verwendungsverfahren dafür
US20070020330A1 (en) *	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) *	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
DOP2006000274A (es)	2005-12-14	2007-10-15	Sanofi Aventis Us Llc	Formulación de suspensión de fexofenadina
EP3090739A1 (de) *	2008-01-04	2016-11-09	Schabar Research Associates LLC	Zusammensetzungen aus naproxen-natriumsalz und nizatidin
CN103446587A (zh) *	2011-12-28	2013-12-18	汪明	肥大细胞抑制剂在制备抗流感病毒感染药物中的应用
EP3086793B1 (de)	2013-12-24	2022-05-11	Virginia Commonwealth University	Verwendung von oxygenierten cholesterinsulfaten (ocs) zur behandlung von nierenstörungen
CA3124579A1 (en)	2020-07-15	2022-01-15	Schabar Research Associates Llc	Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
US12514846B2 (en)	2020-07-15	2026-01-06	Schabar Research Associates Llc	Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
IL299845A (en)	2020-07-15	2023-03-01	Schabar Res Associates Llc	Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4466960A (en) *	1983-10-18	1984-08-21	Thompson Medical Co., Inc.	Analgesic-diuretic compositions
US4552899A (en) *	1984-04-09	1985-11-12	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs

1987
- 1987-06-08 US US07/059,635 patent/US4829064A/en not_active Expired - Fee Related
1988
- 1988-06-06 WO PCT/US1988/001835 patent/WO1988009656A1/en not_active Ceased
- 1988-06-06 AU AU19484/88A patent/AU618010B2/en not_active Ceased
- 1988-06-06 CA CA000568715A patent/CA1313136C/en not_active Expired - Fee Related
- 1988-06-06 DE DE8888905521T patent/DE3873879T2/de not_active Expired - Lifetime
- 1988-06-06 EP EP88905521A patent/EP0316434B2/de not_active Expired - Lifetime
- 1988-06-06 AT AT88905521T patent/ATE79549T1/de not_active IP Right Cessation
1992
- 1992-01-09 CA CA000616280A patent/CA1318851C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE3873879T2 (de)	1993-01-14
EP0316434B2 (de)	1999-06-16
AU1948488A (en)	1989-01-04
EP0316434B1 (de)	1992-08-19
US4829064A (en)	1989-05-09
CA1313136C (en)	1993-01-26
DE3873879D1 (de)	1992-09-24
CA1318851C (en)	1993-06-08
EP0316434A4 (de)	1989-10-16
AU618010B2 (en)	1991-12-12
WO1988009656A1 (en)	1988-12-15
EP0316434A1 (de)	1989-05-24

Legal Events

Date	Code	Title	Description
1993-03-15	UEP	Publication of translation of european patent specification
1999-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE79549T1 (de)	1992-09-15	Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.
DE3854518D1 (de)	1995-11-02	Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.
US4552899B1 (de)	1992-10-20
MX9203278A (es)	1992-07-01	Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
Pierpoint	1994	Salicylic acid and its derivatives in plants: medicines, metabolites and messenger molecules
NO308771B1 (no)	2000-10-30	Filmbelagt, oralt doseringspreparat med forlenget frigivelse
DK372786A (da)	1987-10-16	Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
MX9706769A (es)	1997-11-29	Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
MX9600857A (es)	1997-06-28	Forma de dosificacion i en tabletas, con unidades multiples.
NO880904L (no)	1988-09-05	Farmasoeytisk tablett, farmasoeytisk granulat og fremgangsmaate for deres fremstilling.
ATE145551T1 (de)	1996-12-15	Brausedosisform sowie verfahren zu deren verabreichung
MX9405219A (es)	1995-01-31	Nueva formulacion farmaceutica.
ES2079485T3 (es)	1996-01-16	Composiciones farmaceuticas y un dispositivo para administrar las mismas.
DK0421541T3 (da)	1995-10-02	Tabletstruktur, som kan deles
CO5031291A1 (es)	2001-04-27	Composicion farmaceutica
DE69727494D1 (de)	2004-03-11	Tablette
MX9400630A (es)	1994-07-29	6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
NO983926L (no)	1999-03-01	Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer
ES2036670T3 (es)	1993-06-01	Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante.
ES2093779T3 (es)	1997-01-01	Formulacion farmaceutica que contiene diritromicina.
ES1000119Y (es)	1988-06-01	Una tableta farmaceutica para administracion oral
AR023464A1 (es)	2002-09-04	Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados
TR199901958T2 (xx)	1999-12-21	�nfertiliteye kar�� ve fertiliteyi art�rmak i�in bir ila�.
TR199801728A2 (xx)	1999-04-21	Bir ilac�n �retimi i�in sodyum-hidrojen-de�i�tiricisi �nleyicilerinin kullan�m�.
ATE311883T1 (de)	2005-12-15	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat